PHARMAERO ApS: Financial statements 2022
CVR: 32827942
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMAERO ApS (CVR 32827942) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -638,187 and a net result of DKK -650,593 compared with DKK -1,297,000 the year before. Equity in the 2022 report amounted to DKK 71,990. The solvency ratio was 77%.
- Gross Profit
- DKK -638,187
- Profit/Loss
- DKK -650,593
- Equity
- DKK 71,990
- Total Assets
- DKK 93,535
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -638 t. | -651 t. | 72 t. | - |
| 2021 | 0 | 0 | -1.3 mio. | 3.5 mio. | - |
| 2020 | 149 t. | 149 t. | -1.8 mio. | 4.8 mio. | 0 |
| 2019 | 29 t. | 29 t. | -12.2 mio. | 6.6 mio. | 1 |
| 2018 | - | - | -132.3 mio. | 6.7 mio. | 1 |
Official annual report
Keep an eye on PHARMAERO ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of July 8, 2022, Aleksandar Danilovski has left the board of directors of PHARMAERO ApS.
As of July 8, 2022, Mikkel Lyager Olsen has left the board of directors of PHARMAERO ApS.
As of July 8, 2022, Carl-Åke Carlsson has left the board of directors of PHARMAERO ApS.
As of July 8, 2022, Robert Weeden Irish has left the board of directors of PHARMAERO ApS.
As of July 8, 2022, Markus Puusepp has stepped down as chairman of PHARMAERO ApS.
PHARMAERO ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -1,297,000.
As of March 28, 2022, Robert Weeden Irish has joined the board of directors of PHARMAERO ApS.
As of March 28, 2022, Per Martin Linse has left the board of directors of PHARMAERO ApS.
About PHARMAERO ApS
PHARMAERO ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2010. The company has been dissolved on 15 May 2025. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 1 employee (2019). In 2023, the company reported a gross profit of DKK -18,615 and a net result of DKK -20,072 compared with DKK -650,593 the year before. Equity in the 2023 report amounted to DKK 51,918.